Black Diamond Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $87k | 23k | 3.79 |
| 2025-06-30 | $74k | 30k | 2.48 |
| 2025-03-31 | $103k | 67k | 1.55 |
| 2024-12-31 | $186k | 87k | 2.15 |
| 2024-09-30 | $339k | 78k | 4.34 |
| 2024-06-30 | $121k | 26k | 4.69 |
| 2024-03-31 | $847k | 167k | 5.06 |
| 2023-12-31 | $464k | 167k | 2.78 |
| 2023-09-30 | $921k | 322k | 2.86 |
| 2023-06-30 | $630k | 124k | 5.06 |
| 2023-03-31 | $37k | 19k | 1.91 |
| 2022-12-31 | $35k | 19k | 1.81 |
| 2022-09-30 | $35k | 21k | 1.67 |
| 2022-06-30 | $54k | 22k | 2.46 |
| 2022-03-31 | $73k | 26k | 2.77 |